Cardiac reverse remodeling after SGLT2 inhibitor therapy: exploring beyond sex differences

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Silvia Prosperi

Sapienza University of Rome, Rome (Italy)

4 More presentations in this session

Presentation thumbnail

EPA:DHA 6:1 prevents right ventricular dysfunction and lung vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats by mitigating inflammatory and pro-oxidant responses

Doctor S. AMISSI (Strasbourg, FR)

Abstract Slides Video

Presentation thumbnail

Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting

Doctor B. Chung (Kuching, MY)

Abstract Slides Video

Presentation thumbnail

Echocardiographic parameters in patients with right heart failure and sarcopenia.

Doctor M. Hernandez Hernandez (Mexico City, MX)

Abstract Slides Video

Presentation thumbnail

Multiparametric approach to predict long-term survival in ischemic heart failure patients undergoing surgical ventricular reconstruction

Doctor G. Guida (San Donato Milanese, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiac remodeling across the ejection fraction spectrum

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

Congress Presentation

Deformation Imaging by Strain in Chronic heart failure Over gliflozins: an Echocardiographic Register on Sodium-GLucose coTransporter-2 inhibitors (DISCOVER SGLT2i)

Congress Presentation

Cardiac reverse remodeling and SGLT2ii: insight from hemodynamic forces analysis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources